Evans Marie, Grams Morgan E, Sang Yingying, Astor Brad C, Blankestijn Peter J, Brunskill Nigel J, Collins John F, Kalra Philip A, Kovesdy Csaba P, Levin Adeera, Mark Patrick B, Moranne Olivier, Rao Panduranga, Rios Pablo G, Schneider Markus P, Shalev Varda, Zhang Haitao, Chang Alex R, Gansevoort Ron T, Matsushita Kunihiro, Zhang Luxia, Eckardt Kai-Uwe, Hemmelgarn Brenda, Wheeler David C
Division of Renal Medicine, CLINTEC, Karolinska Institutet, Stockholm, Sweden.
Swedish Renal Registry, Jönköping, Sweden.
Kidney Int Rep. 2018 Jan 11;3(3):625-637. doi: 10.1016/j.ekir.2018.01.002. eCollection 2018 May.
Patients with chronic kidney disease (CKD) and estimated glomerular filtration rate (eGFR) <30 ml/min per 1.73 m (corresponding to CKD stage G4+) comprise a minority of the overall CKD population but have the highest risk for adverse outcomes. Many CKD G4+ patients are older with multiple comorbidities, which may distort associations between risk factors and clinical outcomes.
We undertook a meta-analysis of risk factors for kidney failure treated with kidney replacement therapy (KRT), cardiovascular disease (CVD) events, and death in participants with CKD G4+ from 28 cohorts ( = 185,024) across the world who were part of the CKD Prognosis Consortium.
In the fully adjusted meta-analysis, risk factors associated with KRT were time-varying CVD, male sex, black race, diabetes, lower eGFR, and higher albuminuria and systolic blood pressure. Age was associated with a lower risk of KRT (adjusted hazard ratio: 0.74; 95% confidence interval: 0.69-0.80) overall, and also in the subgroup of individuals younger than 65 years. The risk factors for CVD events included male sex, history of CVD, diabetes, lower eGFR, higher albuminuria, and the onset of KRT. Systolic blood pressure showed a U-shaped association with CVD events. Risk factors for mortality were similar to those for CVD events but also included smoking. Most risk factors had qualitatively consistent associations across cohorts.
Traditional CVD risk factors are of prognostic value in individuals with an eGFR <30 ml/min per 1.73 m, although the risk estimates vary for kidney and CVD outcomes. These results should encourage interventional studies on correcting risk factors in this high-risk population.
慢性肾脏病(CKD)且估算肾小球滤过率(eGFR)<30 ml/(min·1.73 m²)(相当于CKD G4+期)的患者在整个CKD人群中占少数,但不良结局风险最高。许多CKD G4+期患者年龄较大且合并多种疾病,这可能会使风险因素与临床结局之间的关联产生偏差。
我们对来自全球28个队列(n = 185,024)、属于CKD预后联盟的CKD G4+期参与者进行了一项荟萃分析,这些参与者接受了肾脏替代治疗(KRT)、发生心血管疾病(CVD)事件及死亡的风险因素。
在完全调整的荟萃分析中,与KRT相关的风险因素包括随时间变化的CVD、男性、黑人种族、糖尿病、较低的eGFR、较高的蛋白尿和收缩压。总体而言,年龄与KRT风险较低相关(调整后风险比:0.74;95%置信区间:0.69 - 0.80),在65岁以下的亚组中也是如此。CVD事件的风险因素包括男性、CVD病史、糖尿病、较低的eGFR、较高的蛋白尿以及开始KRT。收缩压与CVD事件呈U型关联。死亡的风险因素与CVD事件相似,但还包括吸烟。大多数风险因素在各队列之间具有定性一致的关联。
传统的CVD风险因素对eGFR<30 ml/(min·1.73 m²)的个体具有预后价值,尽管肾脏和CVD结局的风险估计有所不同。这些结果应鼓励对该高危人群中纠正风险因素的干预性研究。